112 related articles for article (PubMed ID: 2598311)
21. [Synthesis of 1,4-dihydropyridines with blood pressure and blood-fat lowering effects].
Zhang S; Zhao D; Mei Q; Feng R
Yao Xue Xue Bao; 1998 Oct; 33(10):789-92. PubMed ID: 12016935
[TBL] [Abstract][Full Text] [Related]
22. Antihypertensive dihydropyridines with 1,4,4-trisubstitution.
Kukla MJ; Breslin HJ; Gill A
J Med Chem; 1990 Jan; 33(1):223-8. PubMed ID: 2296021
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
Bergmann R; Gericke R
J Med Chem; 1990 Feb; 33(2):492-504. PubMed ID: 2299619
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
25. Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity.
Cho H; Ueda M; Shima K; Mizuno A; Hayashimatsu M; Ohnaka Y; Takeuchi Y; Hamaguchi M; Aisaka K; Hidaka T
J Med Chem; 1989 Oct; 32(10):2399-406. PubMed ID: 2552119
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
[TBL] [Abstract][Full Text] [Related]
27. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride.
Ashimori A; Uchida T; Ohtaki Y; Tanaka M; Ohe K; Fukaya C; Watanabe M; Kagitani M; Yokoyama K
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):108-11. PubMed ID: 2049794
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
30. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
Satoh Y; Ichihashi M; Okumura K
Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
[TBL] [Abstract][Full Text] [Related]
33. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiallergic activity of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]-1,4-dihydro-4-oxopyridine-3 - carboxamides.
Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H; Matsumoto J
Chem Pharm Bull (Tokyo); 1989 May; 37(5):1256-9. PubMed ID: 2483534
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
38. Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies.
Zhou XF; Yang X; Wang Q; Coburn RA; Morris ME
Drug Metab Dispos; 2005 Aug; 33(8):1220-8. PubMed ID: 15908473
[TBL] [Abstract][Full Text] [Related]
39. 1,4-Dihydropyridines--a basis for developing new drugs.
Bossert F; Vater W
Med Res Rev; 1989; 9(3):291-324. PubMed ID: 2666803
[No Abstract] [Full Text] [Related]
40. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
